These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1673122)

  • 1. Neuroleptic withdrawal.
    Maisami M; Golant D
    J Am Acad Child Adolesc Psychiatry; 1991 Mar; 30(2):336. PubMed ID: 1673122
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety of the combination of lithium and neuroleptic drugs.
    Goldney RD; Spence ND
    Am J Psychiatry; 1986 Jul; 143(7):882-4. PubMed ID: 2872825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholinergic rebound in neuroleptic withdrawal syndromes.
    Lieberman J
    J Clin Psychiatry; 1981 Apr; 42(4):179. PubMed ID: 6110656
    [No Abstract]   [Full Text] [Related]  

  • 4. Risperidone: new indication. Behavioural disorders in children with autism or mental disabilities: no progress.
    Prescrire Int; 2006 Apr; 15(82):43-5. PubMed ID: 16602211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acute recurrent dystonia secondary to neuroleptic suppression].
    Modrego Pardo P; Pérez Trullen JM
    Rev Clin Esp; 1997 Mar; 197(3):211-2. PubMed ID: 9273591
    [No Abstract]   [Full Text] [Related]  

  • 6. Neuroleptic malignant syndrome related to a switch to perospirone and anticholinergic withdrawal.
    Tanii H; Fujita K; Okazaki Y
    Am J Psychiatry; 2006 Mar; 163(3):547-8. PubMed ID: 16513884
    [No Abstract]   [Full Text] [Related]  

  • 7. Psychiatric drug treatment in children.
    Heath A
    J Maine Med Assoc; 1979 May; 70(5):181-9. PubMed ID: 36437
    [No Abstract]   [Full Text] [Related]  

  • 8. Lithium and neuroleptic drug combination: lack of an effect on blood glucose.
    King DJ
    Br J Clin Pharmacol; 1978 Nov; 6(5):436-7. PubMed ID: 31896
    [No Abstract]   [Full Text] [Related]  

  • 9. Neuroleptic malignant syndrome precipitated by haloperidol following clozapine discontinuation.
    Mendhekar DN; Jiloha RC
    Aust N Z J Psychiatry; 2005 Oct; 39(10):947-8. PubMed ID: 16168023
    [No Abstract]   [Full Text] [Related]  

  • 10. Neuroleptic malignant syndrome with use of quetiapine in mental retardation.
    Dan A; Bharadwaj R; Grover S
    Psychiatry Clin Neurosci; 2009 Apr; 63(2):255-6. PubMed ID: 19335404
    [No Abstract]   [Full Text] [Related]  

  • 11. Dysphoria associated with neuroleptic withdrawal in an adolescent with Tourette's disorder.
    Braña-Berríos M; Lam K; Coffey B
    J Child Adolesc Psychopharmacol; 2011 Aug; 21(4):371-4. PubMed ID: 21851194
    [No Abstract]   [Full Text] [Related]  

  • 12. Lithium.
    DePaulo JR
    Psychiatr Clin North Am; 1984 Sep; 7(3):587-99. PubMed ID: 6384961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroleptic malignant syndrome-like reaction precipitated by antipsychotics in a patient with gamma-butyrolactone withdrawal.
    Eiden C; Capdevielle D; Deddouche C; Boulenger JP; Blayac JP; Peyrière H
    J Addict Med; 2011 Dec; 5(4):302-3. PubMed ID: 21817917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroleptic malignant syndrome and clozapine withdrawal at the same time?
    Margetić B; Aukst-Margetić B
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):145-7. PubMed ID: 15610957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of clozapine-associated tardive dyskinesia.
    Lin CC; Bai YM; Chen JY; Wang YC; Liou YJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):599-600. PubMed ID: 17920744
    [No Abstract]   [Full Text] [Related]  

  • 16. [Unwanted drug effects of psychotropic drugs in neurologic practice].
    Schmidt LG; Schüssler G; Linden M; Müller-Oerlinghausen B
    Nervenarzt; 1985 Jan; 56(1):19-24. PubMed ID: 2858064
    [No Abstract]   [Full Text] [Related]  

  • 17. Clozapine in tardive Tourette syndrome.
    Jaffe E; Trémeau F; Sharif Z; Reider R
    Biol Psychiatry; 1995 Aug; 38(3):196-7. PubMed ID: 7578666
    [No Abstract]   [Full Text] [Related]  

  • 18. Delirium and persistent dyskinesia induced by a lithium-neuroleptic interaction.
    Normann C; Brandt C; Berger M; Walden J
    Pharmacopsychiatry; 1998 Sep; 31(5):201-4. PubMed ID: 9832353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The neuroleptic malignant syndrome].
    Duarte J; García Viejo MA; García Miguel FJ; Sempere AP
    Med Clin (Barc); 1994 Oct; 103(14):558. PubMed ID: 7799673
    [No Abstract]   [Full Text] [Related]  

  • 20. Tardive tourettism after exposure to neuroleptic therapy.
    Bharucha KJ; Sethi KD
    Mov Disord; 1995 Nov; 10(6):791-3. PubMed ID: 8749999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.